mRNA

Discover the landscape of mRNA in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and intelligence on mRNA, helping you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases
CompanyR&D

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

Brii Biosciences Limited (HKG: 2137) announced the launch of its proprietary BRiSC (Bispecific RNAi iSilenCing) small interfering RNA (siRNA) drug discovery platform, designed to advance the development of next‑generation ribonucleic…

AbbVie's RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

AbbVie’s RINVOQ Wins NMPA Approval for Severe Alopecia Areata – Ninth Indication in China Three Months After EU Clearance

CSPC Pharmaceutical's Trispecific Antibody SYS6088 Wins NMPA Clinical Trial Approval – PD‑1/VEGFA/CTLA‑4 Candidate Targets Advanced and Metastatic Solid Tumors

CSPC Pharmaceutical’s Trispecific Antibody SYS6088 Wins NMPA Clinical Trial Approval – PD‑1/VEGFA/CTLA‑4 Candidate Targets Advanced and Metastatic Solid Tumors

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Walvax Biotechnology Announces Positive Results for RQ3013 mRNA Vaccine

CompanyDeals

HuiLiao Biomedical Raises RMB 100 Million in Pre-Series A Round for mRNA Development

CompanyDeals

HealiRNA Secures RMB 100 Million in Pre-Series A Funding for Nucleic Acid Drug Development

CompanyDeals

Alphamab Oncology Partners with Stemirna for BsAb and mRNA Vaccine Development

CompanyDeals

RinuaGene Raises $14.4M in Pre-Series A+ for mRNA Drug Development

CompanyDeals

Asieris Partners with ReviR Therapeutics for Urogenital Cancer Research

CompanyDrug

CNBG-Virogin’s Omicron-Targeted mRNA Vaccine Approved for Clinical Trials

CompanyDrug

CanSino Biologics’ mRNA Vaccine CS-2034 Shows Positive Safety and Immunogenicity Data

Show More